COVID-19: Indonesia to provide vaccines to 9.1 million people at 1st phase
Advertisement
Jakarta: Indonesia will at the first phase provide the Covid-19 vaccine to 9.1 million people between November and December 2020, the Health Ministry's Disease Control and Prevention Director General Achmad Yurianto said.
The first phase of vaccination will be carried out on the groups of people with highest risk of Covid-19 infections, namely medical and public service workers including airport employees, soldiers and police personnel, Xinhua news agency reported on Monday.
Yurianto said that the vaccine would only be given to people aged between 18 years old and 59 years old, because clinical trials of vaccine candidates in the world have yet to target categories outside that age range.
The vaccination will be carried out after the Indonesian Drug and Food Supervisory Agency (BPOM) issues an emergency use authorization and the Indonesian Ulema Council (MUI) provides halal certification.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.